Altrazeal Life Sciences Inc.
Altrazeal Life Sciences Inc. is a specialty medical technology company dedicated to developing and commercializing innovative drug delivery systems. Their mission is to improve patient outcomes by providing comprehensive solutions for patients, providers, and payers. The company is known for its patented Altrazeal® Transforming Powder Dressing, which optimizes the wound healing environment and supports tissue repair.
Industries
Nr. of Employees
small (1-50)
Altrazeal Life Sciences Inc.
Altrazeal Life Sciences Inc. 15020 Beltway Drive Addison, TX 75001 United States of America
Awards
Developing an Ideal Wound Care Platform : Altrazeal Transforming Powder
Funding (ceiling)
$3,965,567.89
Award Year
2020
Patents
Hydrogel wound dressing and biomaterials formed in situ and their uses
2011-03-22 • US-7910135-B2
View DetailsMethod of formation of shape-retentive aggregates of gel particles and their uses
2010-10-12 • US-7811605-B2
View Details
Hydrogel wound dressing and biomaterials formed in situ and their uses
2011-03-22 • US-7910135-B2
View DetailsMethod of formation of shape-retentive aggregates of gel particles and their uses
2010-10-12 • US-7811605-B2
View DetailsProducts
Transforming polymer powder wound dressing
Sterile polymer granule powder that hydrates on moist wounds to form a flexible, oxygen‑permeable matrix which conforms to and seals the wound bed; engineered for exudate control via moisture absorption and vapor transmission, non‑adherence to intact skin, saline‑assisted removal or natural shedding, and extended wear to reduce dressing changes.
Water‑erodible multilayer transmucosal delivery device
A multi‑layer, water‑erodible carrier designed to adhere to mucosal surfaces and release active pharmaceutical ingredients locally or systemically with controlled erosion and release profiles.
Transforming polymer powder wound dressing
Sterile polymer granule powder that hydrates on moist wounds to form a flexible, oxygen‑permeable matrix which conforms to and seals the wound bed; engineered for exudate control via moisture absorption and vapor transmission, non‑adherence to intact skin, saline‑assisted removal or natural shedding, and extended wear to reduce dressing changes.
Water‑erodible multilayer transmucosal delivery device
A multi‑layer, water‑erodible carrier designed to adhere to mucosal surfaces and release active pharmaceutical ingredients locally or systemically with controlled erosion and release profiles.
Expertise Areas
- Wound‑care product design and materials engineering
- Clinical trial execution and clinical evidence generation
- Clinical protocol and application development for complex wounds
- Extended‑wear dressing systems and exudate management
Key Technologies
- Methacrylate‑based powder polymer matrices
- High moisture vapor transmission polymer matrices
- Moisture‑absorbing polymer granule formulations
- Water‑erodible multilayer transmucosal carriers
Key People
Chairperson, CEO
COO, Director
VP Special Projects, Director
Director
Director
Board Observer
Chairperson, CEO
COO, Director
VP Special Projects, Director
Director
Director
Board Observer
Featured In Technology Showcase
Developing an Ideal Wound Care Platform - Altrazeal Transforming Powder
ULURU Inc., supported by NAMD and MTEC, is advancing Altrazeal®, a novel wound care technology designed for extended wear in acute and chronic wounds. Altrazeal’s polymer-based powder forms a protective, oxygen-permeable matrix, reducing dressing changes and promoting healing. Already in use in civilian and veteran health systems, MTEC funding is accelerating clinical trials and expanding adoption. Additional grants support its use in military, surgical, and low-resource settings worldwide.
News & Updates
This article discusses the innovative use of transforming powder dressing in treating various chronic wounds.
This study evaluates the cost-effectiveness of using transforming powder dressing compared to standard wound care.
This article presents outcomes from three patients treated with transforming powder dressing for chronic venous leg ulcers.
This article discusses the innovative use of transforming powder dressing in treating various chronic wounds.
This study evaluates the cost-effectiveness of using transforming powder dressing compared to standard wound care.
This article presents outcomes from three patients treated with transforming powder dressing for chronic venous leg ulcers.